Published in Arch Dis Child on November 01, 2001
How I treat hemophagocytic lymphohistiocytosis. Blood (2011) 5.08
Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol (2011) 1.67
Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis (2006) 1.41
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther (2004) 1.33
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum (2008) 1.33
Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol (2010) 1.20
What nephrologists need to know about hemophagocytic syndrome. Nat Rev Nephrol (2009) 1.17
Unusual presentation of congenital disorder of glycosylation type 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedema. Eur J Pediatr (2005) 1.10
Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol (2014) 1.09
Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol (2014) 1.06
Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr Clin North Am (2012) 1.05
Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol (2014) 1.04
Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis. Arthritis Res Ther (2010) 1.01
Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning. Front Immunol (2014) 1.00
Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol (2012) 1.00
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis (2004) 0.98
Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics (2010) 0.96
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report. Pediatr Rheumatol Online J (2014) 0.95
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) (2013) 0.95
Systemic arthritis in children: a review of clinical presentation and treatment. Int J Inflam (2011) 0.94
Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore) (2015) 0.91
Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome. Clin Vaccine Immunol (2011) 0.91
Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol (2013) 0.90
Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis. Arthritis Rheum (2008) 0.88
Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis. Korean J Pediatr (2010) 0.88
Life-threatening complications of adult-onset Still's disease. Clin Rheumatol (2014) 0.87
Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis. Rheumatol Int (2008) 0.87
2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care Res (Hoboken) (2013) 0.86
Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy. Rheumatol Int (2010) 0.83
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol (2015) 0.82
Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum (2012) 0.82
Hepatic inflammatory pseudotumor presenting in an 8-year-old boy: A case report and review of literature. World J Gastroenterol (2015) 0.81
Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease. Blood Res (2013) 0.80
Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade. Curr Opin Rheumatol (2016) 0.80
Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis. Ther Adv Musculoskelet Dis (2012) 0.80
Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan. Ann Rheum Dis (2015) 0.79
Relapsing macrophage activating syndrome in a 15-year-old girl with Still's disease: a case report. J Med Case Rep (2009) 0.78
Macrophage activation syndrome in a child with systemic juvenile rheumatoid arthritis. J Korean Med Sci (2005) 0.78
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open (2016) 0.78
Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int (2016) 0.78
Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Pharmaceuticals (Basel) (2015) 0.78
Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis. Arch Dis Child (2003) 0.77
Targeting the inflammasome in rheumatic diseases. Transl Res (2015) 0.77
Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol (2016) 0.76
Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India. Rheumatol Int (2011) 0.76
Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J (2015) 0.76
Acute hepatitis in three patients with systemic juvenile idiopathic arthritis taking interleukin-1 receptor antagonist. Pediatr Rheumatol Online J (2009) 0.76
Large pericardial effusion requiring pericardiocentesis as cardinal sign of macrophage activation syndrome in systemic onset-juvenile idiopathic arthritis. Rheumatol Int (2006) 0.76
Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome. Pediatr Rheumatol Online J (2011) 0.76
Lung Involvement in Children with Hereditary Autoinflammatory Disorders. Int J Mol Sci (2016) 0.75
Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis. Reumatologia (2016) 0.75
An important complication of a child with juvenile idiopathic arthritis: macrophage activation syndrome. BMJ Case Rep (2013) 0.75
Hemophagocytic lymphohistiocytosis secondary to hemodialysis catheter-related blood stream infection. Indian J Nephrol (2017) 0.75
A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment. JCI Insight (2016) 0.75
Macrophage activation syndrome triggered by coeliac disease: a unique case report. Pediatr Rheumatol Online J (2016) 0.75
Combination Immunosuppressive Therapy Including Rituximab for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adult-Onset Still's Disease. Case Rep Rheumatol (2016) 0.75
Pleuritic chest pain; where should we search for? Iran J Pediatr (2011) 0.75
Evaluation of children with juvenile idiopathic arthritis in southeastern Turkey: a single center experience. Hippokratia (2015) 0.75
MEFV gene polymorphisms and TNFRSF1A mutation in patients with inflammatory myopathy with abundant macrophages. Clin Exp Immunol (2014) 0.75
Macrophage activation syndrome in malaria. Rheumatol Int (2009) 0.75
Toward an Inclusive, Congruent, and Precise Definition of Autoinflammatory Diseases. Front Immunol (2017) 0.75
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol (2017) 0.75
New frontiers in the treatment of systemic juvenile idiopathic arthritis. F1000Res (2017) 0.75
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest (1998) 6.76
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol (2000) 5.55
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis (2005) 4.17
Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys (1992) 2.84
Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum (1999) 2.39
Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? Rheumatology (Oxford) (2005) 2.28
Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol (1982) 2.20
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) (2005) 2.19
Trypanosomes in cattle in southern Ontario. Can J Comp Med (1970) 2.02
Childhood-onset scleroderma: is it different from adult-onset disease. Arthritis Rheum (1996) 1.85
Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol (1988) 1.83
Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy. J Rheumatol (2001) 1.82
Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol (2006) 1.80
Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem (1985) 1.79
Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg (1996) 1.77
A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol (1990) 1.76
Controlled comparison of short-wave diathermy treatment with osteopathic treatment in non-specific low back pain. Lancet (1985) 1.74
Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor kappaB-like transcription factor. Mol Cell Biol (1989) 1.63
Juvenile chronic arthritis: diagnosis and management of tibio-talar and sub-talar disease. Br J Rheumatol (1997) 1.62
Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet (1998) 1.59
Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J Biol Chem (1992) 1.57
Childhood arthritis: the name game. Br J Rheumatol (1993) 1.55
Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol (1996) 1.54
Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum (2000) 1.50
The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem (1993) 1.46
Tolerance to propofol generally does not develop in pediatric patients undergoing radiation therapy. Anesthesiology (1996) 1.44
Requirements for occupational medicine training in Europe: a Delphi study. Occup Environ Med (2000) 1.44
Vertebral artery injury during anterior decompression of the cervical spine. A retrospective review of ten patients. J Bone Joint Surg Br (1993) 1.41
The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. J Neurosurg (1993) 1.40
Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) (2002) 1.39
Jet ventilation in upper airway obstruction: description and model lung testing of a new jetting device. Anesth Analg (1998) 1.39
Human serum amyloid A has cytokine-like properties. Scand J Immunol (1998) 1.39
Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate? Cancer (1992) 1.38
Combined genetic deficiency of C6 and C7 in man. Clin Exp Immunol (1978) 1.38
Whole-gut perfusion for therapeutic purgation. Br Med J (1976) 1.34
Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) (2004) 1.32
Use of a community-based touch-screen public-access health information system. Health Bull (Edinb) (1993) 1.28
A 5-HT4-like receptor in human right atrium. Naunyn Schmiedebergs Arch Pharmacol (1991) 1.27
The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr. Rheumatology (Oxford) (2006) 1.25
Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol (1995) 1.25
A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J (1989) 1.23
Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin Exp Immunol (1991) 1.22
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum (2008) 1.20
Tracheobronchial abnormalities in infants with bronchopulmonary dysplasia. J Pediatr (1987) 1.18
Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2). Br J Rheumatol (1997) 1.16
Characterization of a phosphorylation-activated Cl-selective channel in isolated Necturus enterocytes. J Physiol (1989) 1.14
The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol (2001) 1.14
Cross-talk between transcription factors NF-kappa B and C/EBP in the transcriptional regulation of genes. Int J Biochem Cell Biol (1997) 1.10
Amino acid sequence of the phosphorylation site of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J Biol Chem (1984) 1.09
Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun (2004) 1.09
Benign joint hypermobility in childhood. Rheumatology (Oxford) (2001) 1.09
PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it. Ann Rheum Dis (2005) 1.09
Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum (1993) 1.08
Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol (2001) 1.07
Differential effects of proteolysis and protein modification on the activities of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J Biol Chem (1984) 1.07
Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology (Oxford) (2008) 1.07
Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol (2001) 1.06
Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford) (2002) 1.06
Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant (1997) 1.04
Glottal area waveform analysis of benign vocal fold lesions before and after surgery. Ann Otol Rhinol Laryngol (2000) 1.04
HLA-B27 subtypes in the spondarthropathies. Clin Exp Immunol (1993) 1.03
Biomechanics of arytenoid adduction surgery in an ex vivo canine model. Ann Otol Rhinol Laryngol (1998) 1.03
Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol (1993) 1.03
Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys (1997) 1.01
Multiplication of Trypanosoma brucei and Trypanosoma congolense in vertebrate hosts. Trans R Soc Trop Med Hyg (1969) 1.01
Stroboscopic signs associated with benign lesions of the vocal folds. J Voice (1995) 1.00
Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02. Cancer (1995) 1.00
The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol (1991) 1.00
Partial purification and some properties of rat brain inositol 1,4,5-trisphosphate 3-kinase. Biochem J (1988) 0.99
Amyloidosis in the rheumatic diseases. Ann Rheum Dis (1989) 0.99
Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis. Br J Rheumatol (1998) 0.99
Constitutive and NF-kappa B-like proteins in the regulation of the serum amyloid A gene by interleukin 1. Cytokine (1991) 0.99
A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis. Cytokine (1998) 0.98
Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Rheumatology (Oxford) (2004) 0.98
Human serum amyloid A protein. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem (1989) 0.97
Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis. Genes Immun (2008) 0.97
Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum (1996) 0.97
Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford) (2002) 0.96
Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. Health Technol Assess (2005) 0.96
Analysis of sickness absence among employees of four NHS trusts. Occup Environ Med (1999) 0.96
Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J Rheumatol (2001) 0.96
Upper aerodigestive tract liposarcoma: report on four cases and literature review. Laryngoscope (1999) 0.95
Clinical variability and genetic homogeneity of the camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Am J Med Genet (2000) 0.94
Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Ann Rheum Dis (2007) 0.94
Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group. Eur J Cancer (1997) 0.94
School attendance and juvenile chronic arthritis. Br J Rheumatol (1997) 0.93
Anti-tumour necrosis factor therapy associated with cutaneous vasculitis. Rheumatology (Oxford) (2002) 0.92
Identification of a novel regulatory region in the interleukin-6 gene promoter. Cytokine (2008) 0.92
The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions. Immunology (2001) 0.92